REGAN HOUSTON: Open Payments
NPI 1376132803 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 15 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $179 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $106 |
| ABBVIE INC. | 4 | $105 |
| Lilly USA, LLC | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: QULIPTA, MOUNJARO, XIFAXAN, Ozempic, UBRELVY, Rybelsus, Symbravo, VOQUEZNA.
Industry payments across VA — which companies pay providers there.
